ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Breaking News! The Second ADC Approved for Marketing in China PharmaSources/Xiaoyaowan
May 21, 2020According to the NMPA website on May 13, the marketing application for Brentuximab Vedotin Injection filed by Takeda Pharmaceutical in China has been reviewed and approved, to become the second ADC approved for marketing in China.
Pharma Sources Insight January 2025
